Targeted Therapies Improve Prognosis for Lung Cancer Patients
February, 2012 — CollabRx’s Lung Cancer Targeted Therapy Finder and Dr. Ravi Salga, chief editor and advisor for the Lung Cancer Targeted Therapy Finder, are featured in an article published by the...
View ArticleLung Cancer Molecular Disease Model Published in PLoS ONE
A team including leading lung cancer researchers, and CollabRx scientists, has just published a novel Lung Cancer Molecular Disease Model in PLoS ONE, a leading peer-reviewed open source journal....
View ArticleColon Cancer Genome Analysis Reveals New Targets
Work appearing in the July 19th issue of Nature reports a comprehensive genomic analysis of colon and rectal cancer, combining data from 276 tumor samples. Involving more than 150 researchers at dozens...
View ArticleLife Tech, CollabRx Ink Deal to Elucidate MDx Information
The post Life Tech, CollabRx Ink Deal to Elucidate MDx Information appeared first on CollabRx, Inc..
View ArticleLife Technologies, CollabRx forge molecular Dx data deal
The post Life Technologies, CollabRx forge molecular Dx data deal appeared first on CollabRx, Inc..
View ArticleNewly Public CollabRx Sees ‘Explosive Growth Potential’ for Informatics-based...
By Uduak Grace Thomas CollabRx officials see “explosive growth potential” for the company’s target market of informatically guided genomic medicine, according to comments made during the firm’s first...
View ArticleLife Tech Relies on Partners, Acquisitions to Develop Personalized Rx...
October 10, 2012 By Turna Ray Life Technologies is tapping the expertise of several personalized medicine companies — some through partnerships and others through acquisitions — to develop a...
View ArticleCollabRx Featured in Forbes Article: “Can We Build A Kickstarter For Cancer?”
SAN FRANCISCO, Calif., August 5, 2013 — CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured a Forbes article “Can We Build...
View ArticleCollabRx Launches Variant Interpretation Service With Initial Focus on Oncology
By Uduak Grace Thomas CollabRx this week launched its Genetic Variant Annotation, or GVA, service, which will provide variant interpretation services to the molecular diagnostics segment of the...
View ArticleCollabRx Partners with Medical News Site to Launch Molecular Oncology Mobile App
By Uduak Grace Thomas Last week, CollabRx announced that it is collaborating with MedPage Today, the medical news arm of digital health and wellness firm Everyday Health, to develop a mobile...
View Article
